THE Seventh EUROSYMPOSIUM ON HEALTHY AGEING : November 2024.
  • Home
  • Program (2024)
  • Program (2022)
  • Abstracts
  • Registration
  • Declarations
  • Sponsoring
  • Previous EHA conferences
  • How to organize clinical trials on longevity
  • Declaration (Old)

Day 1 (October 1st)


​Day Chair: Sven Bulterijs


08:00-09:00 Registration
09:00-09:15 Welcome remarks: Sven Bulterijs (Heales vzw, Belgium)

1. Genetics of Longevity

09:15-09:25 Joao Pedro de Magalhaes (University of Liverpool, UK)
Sequencing the genome of the longest-lived mammal to identify longevity assurance mechanisms

09:25-09:45 Ana Valdes (University of Nottingham, UK)
Omic markers of aging using twin studies

2. Longevity, Genes and the Extracellular Matrix

09:45-10:25 Leslie Roberts (Hopital Dieu, France)
Longevity and Aging, role of genes and extracellular matrix (ECM)

10:25-10:45 Coffee

3. Glycation in Aging

10:45-11:05 Andreas Simm (University Hospital Halle (Saale), Germany)
Protein glycation: between tissue aging and protection against lung tumor formation

11:05-11:25 Sven Bulterijs (Heales vzw, Belgium)
Chemical tools to study AGEing

11:25-11:45 William Bains (MIT, US)
Advanced Glycation End-products as therapeutic targets: prevent, remove or ignore?
11:45-13:15 Lunch

4. Keynote lecture

13:15-14:15 Holly Brown-Borg (University of North Dakota, USA)
Growth hormone and methionine: Are these factors linked to aging and longevity?

5. Senescence

14:15-14:35 Ken Parkinson (Queen Mary, University of London, UK)
The extracellular metabolome of replicative- and irreparable DNA double strand break-induced senescence overlaps with the age-related metabolome of organs in vivo

14:35-14:55 Daniel Muñoz (Centro Nacional de Investigaciones Oncológicas, Spain)  
Cellular senescence in tissue remodeling: from physiology to pathology.

14:55-15:15 Coffee

6. Proteostasis

15:15-15:25 Violaine Planté-Bordeneuve (Réseau amylose et DHU A-TVB, France)
The role of aging in transthyretin amyloidosis (ATTR)

15:25-15:45 Janne Johansson (Karolinska Institutet, Sweden)
BRICHOS - a proprotein domain that prevents amyloid fibril toxicity

15:45-16:00 Martin Denzel (Max Planck Institute, Germany)
Activation of an endogenous metabolic pathway extends health- and lifespan
7. Panel session

16:00-17:00 Hallmarks of Ageing
Moderator: Sven Bulterijs
Panel members: Aubrey de Grey, Graham Pawelec, Christian Bar

18:00 Informal meeting
Location: A La Mort Subite (rue Montagne-aux-Herbes Potagères 7, Brussels)
​

Day 2 (October 2nd) ​


​Day Chair: Peter Wicks

1. Brain Aging 

08:30-08:50 Lorenzo Magrassi (University of Pavia, Italy)
Is there a maximum lifespan for neurons?

08:50-09:10 Jennifer Pocock (University College London, UK)

2. Stem Cells and Regenerative Medicine

09:10-09:30 Wolfgang Wagner (RWTH Aachen University Medical School, Germany)
DNA Methylation Changes in Replicative Senescence and Aging

09:30-09:50 Jean-Marc Lemaitre (Institute of Functional Genomics, France)
Exploring strategies for cell rejuvenation and tissues regeneration

09:50-10:10 Coffee 

10:10-10:30 Henne Holstege (VU University Medical Center, The Netherlands)
Somatic mutations found in the healthy blood compartment of a 115-year-old woman demonstrate oligoclonal hematopoiesis

10:30-10:50 Jessie van Hoecke (Catholic University of Leuven, Belgium)
The effect of aging on neuroregenerative capacities: insights from the senescent zebrafish

3. Geroprotective drugs

10:50-11:10 Edouard Debonneuil (International Longevity Alliance)
Geroprotectors; of mice and men

11:10-11:30 Liesbet Temmerman (Catholic University of Leuven, Belgium)
Metformin and healthy aging: mitohormesis is good for you

11:30-11:50 Alex Zhavoronkov (In Silico Medicine, inc., US) 
The properties of universal and personalized geroprotector regiments

11:50-12:10 Sven Bulterijs (Heales vzw)
The Hallmarks of Aging Score as a method to classify geroprotective drugs 

12:10-13:30 Lunch

4. Immunosenescence and Inflammation

13:30-13:50 TBA 

13:50-14:15 Graham Pawelec (University of Tübingen, Germany)
Immunity and ageing: causes and effects of immunosenescence in humans

14:15-14:35 Anne Mieke H. Boots (Rijksuniversiteit Groningen, The Netherlands) 
Ageing of the human immune system in health and disease

14:35-14:55 Catharina Matheï (Catholic University of Leuven, Belgium)

14:55-15:15 Coffee

6. Hormesis

15:15-15:40 Suresh IS Rattan (Aarhus University, Denmark)
Healthy ageing, hormesis and future lines of investigation

7. TBA

15:40-16:00 TBA

8. Panel session

16:00-17:00 The Most Promising Intervention Strategies in Ageing 
Moderator: Edouard Debonneuil (International Longevity Alliance)
Panel members: Joao Pedro de Magalhaes, Aubrey de Grey 

18:00 Informal meeting 
Location: A La Mort Subite (rue Montagne-aux-Herbes Potagères 7, Brussels)

Day 3 (October 3rd)


Day Chair: Alexander Tietz

10:00 - 10:40 Darya Khaltourina (International Longevity Association)
The longevity organizations in the world: Policy, Academic Research, Social Movement

10:40 - 11:10 David Wood (Catalyst and Futurist)
Approaching rejuvenation - reflections from a philosopher of science and a critical futurist

10:40 - 12:00 Kris Verburgh (Heales VZW, Belgium) 
The most promising Intervention strategies in ageing (synthesis)

12:00 - 14:00 Press conference. The future of ageing and longevity: is the sky the limit?
  • Philippe Busquin (former European Commissioner in charge of Research)
  • Didier Coeurnelle (co-chair of Heales)

14:30 - 16:30 Working groups on the future of longevity

  1. Communication and longevity (chaired by Martine Verhaege de Naeyer, press officer of Heales VZW)
  2. Fundraising and longevity (chaired by Edouard Debonneuil, co-chair of Heales VZW)
  3. Resilient longevity organisations (chaired by Peter Wicks, Heales VZW)

16:30 - 17:00 Rapports and proposals from the working groups

17:30 Cloture Speech and Goodbye Drink
Powered by Create your own unique website with customizable templates.
  • Home
  • Program (2024)
  • Program (2022)
  • Abstracts
  • Registration
  • Declarations
  • Sponsoring
  • Previous EHA conferences
  • How to organize clinical trials on longevity
  • Declaration (Old)